It's around 5k for whole genome sequencing atm and some googling showed that you can do exome sequencing for a lot cheaper (it's a very small fraction of human DNA).
This guy seems to think that the flattening of the tail on that graph is due to Illumina not having enough competition rather than being due to technical limitations at the moment.
